AbbVie Reports Second-Quarter 2022 Financial Results
Reports Second-Quarter Diluted EPS of $0.51 on a GAAP Basis, an Increase of 21.4 Percent; Adjusted Diluted EPS of $3.37, an Increase of 11.2 Percent; These...
Source: prnewswire.com
Cugene Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cugene Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cugene Inc Today - Breaking & Trending Today
Weekly Life Science News Round Up: 16th – 20th May
A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 16th-20th May...
Source: pharmiweb.com
AbbVie and Cugene Announce Collaboration in Autoimmune Diseases
AbbVie (NYSE: ABBV) and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines to treat autoimmune disease and cancer, today announced an exclusive worldwide license option agreement for CUG252, a potential best-in-class Treg-selective ...
Source: pharmiweb.com
AbbVie and Cugene Announce Collaboration in Autoimmune Diseases
/PRNewswire/ -- AbbVie (NYSE: ABBV) and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and...
Source: prnewswire.com
AbbVie and Cugene Announce Collaboration in Autoimmune Diseases
AbbVie and Cugene Announce Collaboration in Autoimmune Diseases - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com